Issued Patents All Time
Showing 26–50 of 90 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9801828 | Tamper resistant oral opioid agonist formulations | Benjamin Oshlack, J. David Haddox | 2017-10-31 |
| 9757341 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2017-09-12 |
| 9750736 | Oxycodone formulations | Benjamin Oshlack, Derek Allan Prater | 2017-09-05 |
| 9693961 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2017-07-04 |
| 9655894 | Once-A day oxycodone formulations | Benjamin Oshlack, Derek Allan Prater | 2017-05-23 |
| 9655893 | Once-a-day oxycodone formulations | Benjamin Oshlack, Derek Allan Prater | 2017-05-23 |
| 9561225 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent | Benjamin Oshlack, Christopher Breder | 2017-02-07 |
| 9517207 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2016-12-13 |
| 9456989 | Tamper-resistant oral opioid agonist formulations | Benjamin Oshlack, J. David Haddox | 2016-10-04 |
| 9387174 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2016-07-12 |
| 9387173 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2016-07-12 |
| 9326959 | Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax | Robert D. Colucci, Ahmed El-Tahtawy | 2016-05-03 |
| 9308171 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2016-04-12 |
| 9308170 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2016-04-12 |
| 9289397 | Titratable dosage transdermal delivery system | — | 2016-03-22 |
| 9278073 | Tamper-resistant oral opioid agonist formulations | Benjamin Oshlack, J. David Haddox | 2016-03-08 |
| RE45822 | Oral dosage form comprising a therapeutic agent and an adverse-effect agent | Anthony E. Carpanzano | 2015-12-22 |
| 9101668 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent | Benjamin Oshlack, Christopher Breder | 2015-08-11 |
| 9060976 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2015-06-23 |
| 9044435 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2015-06-02 |
| 9040084 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2015-05-26 |
| 9034377 | Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax | Robert D. Colucci, Ahmed El-Tahtawy | 2015-05-19 |
| 9034376 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2015-05-19 |
| 8999961 | Pharmaceutical formulation containing gelling agent | Benjamin Oshlack, Christopher Breder | 2015-04-07 |
| 8946292 | Formulations of low dose diclofenac and beta-cyclodextrin | Daniel B. Carr, Fred H. Mermelstein | 2015-02-03 |